Please enable JavaScript to continue using this application.

Compare $ABOS vs $ORGO | Chartloom

Compare

$ABOS vs $ORGO

Acumen Pharmaceuticals Inc · Organogenesis Holdings Inc

ABOS

Acumen Pharmaceuticals Inc

ORGO

Organogenesis Holdings Inc

Compare $ABOS vs $ORGO

Comparing Acumen Pharmaceuticals Inc and Organogenesis Holdings Inc

ABOSAcumen Pharmaceuticals Inc

ORGOOrganogenesis Holdings Inc

ABOSAcumen Pharmaceuticals Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.9%

52W performance

13.8%

FCF yield

-59.4%

ORGOOrganogenesis Holdings Inc

Market cap

$166M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.74x

Rev growth (TTM)

6.5%

YTD performance

-72.2%

52W performance

-68.8%

FCF yield

12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABOS

ORGO

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

ORGO

Organogenesis Holdings Inc

Market Cap

ABOS$155M

ORGO$166M

Enterprise Value

ABOS$127M

ORGO$132M

Price

ABOS$2.14

ORGO$1.29

P/E Ratio

ABOSN/A

ORGON/A

P/S Ratio

ABOS102.45x

ORGO0.36x

EV/Sales

ABOS0.00x

ORGO0.29x

EV/EBITDA

ABOS0.00x

ORGO7.37x

P/B Ratio

ABOS2.58x

ORGO0.59x

P/FCF Ratio

ABOSN/A

ORGO7.96x

EV/FCF

ABOS-1.38x

ORGO6.31x

PEG Ratio

ABOSN/A

ORGON/A

Forward P/E (NTM)

ABOSN/A

ORGON/A

Forward P/S (NTM)

ABOSN/A

ORGO0.74x

Revenue (TTM)

ABOS$0

ORGO$457M

Revenue Growth (YoY)

ABOSN/A

ORGO6.5%

Forward Rev Growth

ABOS1135.7%

ORGO37.6%

Gross Margin (TTM)

ABOS0.0%

ORGO70.4%

Operating Margin (TTM)

ABOS0.0%

ORGO0.0%

EBITDA Margin (TTM)

ABOS0.0%

ORGO-2.0%

Net Margin (TTM)

ABOS0.0%

ORGO-23.1%

FCF Margin (TTM)

ABOSN/A

ORGO4.6%

Net Income (TTM)

ABOS$-105M

ORGO$-106M

FCF (TTM)

ABOS$-92M

ORGO$21M

EPS (TTM)

ABOS-$1.45

ORGO-$0.82

ROE (TTM)

ABOS-13627.0%

ORGO-2260.0%

ROA (TTM)

ABOS-8164.0%

ORGO-1654.0%

ROIC (TTM)

ABOS-9709.0%

ORGO-2187.0%

Cash

ABOS$59M

ORGO$46M

Debt

ABOS$32M

ORGO$12M

Net Cash/Debt

ABOS$28M

ORGO$34M

Current Ratio (TTM)

ABOS2.47x

ORGO3.52x

Quick Ratio (TTM)

ABOS2.38x

ORGO2.66x

Debt/Equity (TTM)

ABOS0.55x

ORGO0.04x

Debt/Assets (TTM)

ABOS0.0%

ORGO0.0%

Interest Coverage (TTM)

ABOSN/A

ORGON/A

Net Debt/EBITDA (TTM)

ABOS0.00x

ORGO0.00x

Beta

ABOS0.30

ORGO1.44

52W Performance

ABOS13.8%

ORGO-68.8%

YTD Performance

ABOS5.9%

ORGO-72.2%

% from 52W High

ABOS-40.6%

ORGO-81.8%

% from 52W Low

ABOS42.7%

ORGO3.2%

Asset Turnover (TTM)

ABOS0.00x

ORGO0.90x

FCF Yield (TTM)

ABOS-59.4%

ORGO12.6%

Earnings Yield (TTM)

ABOS-68.0%

ORGO-63.8%

Dividend Yield (TTM)

ABOSN/A

ORGON/A

Rule of 40

ABOS0.0

ORGO11.1

EV/GP/RG

ABOSN/A

ORGO0.01

Ticker research

View ABOS research View ORGO research

Metric	ABOS Acumen Pharmaceuticals Inc	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$155M	$166M
Enterprise Value	$127M	$132M
Price	$2.14	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	2.58x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-1.38x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	1135.7%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-105M	$-106M
FCF (TTM)	$-92M	$21M
EPS (TTM)	-$1.45	-$0.82
ROE (TTM)	-13627.0%	-2260.0%
ROA (TTM)	-8164.0%	-1654.0%
ROIC (TTM)	-9709.0%	-2187.0%
Financial Health
Cash	$59M	$46M
Debt	$32M	$12M
Net Cash/Debt	$28M	$34M
Current Ratio (TTM)	2.47x	3.52x
Quick Ratio (TTM)	2.38x	2.66x
Debt/Equity (TTM)	0.55x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.44
52W Performance	13.8%	-68.8%
YTD Performance	5.9%	-72.2%
% from 52W High	-40.6%	-81.8%
% from 52W Low	42.7%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-59.4%	12.6%
Earnings Yield (TTM)	-68.0%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View ABOS research	View ORGO research

Valuation

P/S Ratio

ORGO

0.36x

ABOS

102.45x

EV/FCF

ABOS

-1.38x

ORGO

6.31x

Growth & revenue

Revenue Growth TTM

ORGO

6.5%

Forward Revenue Growth

ABOS

1135.7%

ORGO

37.6%

Profitability & performance

Gross Margin

ORGO

70.4%

ABOS

0.0%

ROE

ORGO

-2260.0%

ABOS

-13627.0%

FCF Yield %

ORGO

12.6%

ABOS

-59.4%

52-Week Performance

ABOS

13.8%

ORGO

-68.8%

Detailed metrics comparison

ABOS

Acumen Pharmaceuticals Inc

ORGO

Organogenesis Holdings Inc

Market Cap

ABOS$155M

ORGO$166M

Enterprise Value

ABOS$127M

ORGO$132M

Price

ABOS$2.14

ORGO$1.29

P/E Ratio

ABOSN/A

ORGON/A

P/S Ratio

ABOS102.45x

ORGO0.36x

EV/Sales

ABOS0.00x

ORGO0.29x

EV/EBITDA

ABOS0.00x

ORGO7.37x

P/B Ratio

ABOS2.58x

ORGO0.59x

P/FCF Ratio

ABOSN/A

ORGO7.96x

EV/FCF

ABOS-1.38x

ORGO6.31x

PEG Ratio

ABOSN/A

ORGON/A

Forward P/E (NTM)

ABOSN/A

ORGON/A

Forward P/S (NTM)

ABOSN/A

ORGO0.74x

Revenue (TTM)

ABOS$0

ORGO$457M

Revenue Growth (YoY)

ABOSN/A

ORGO6.5%

Forward Rev Growth

ABOS1135.7%

ORGO37.6%

Gross Margin (TTM)

ABOS0.0%

ORGO70.4%

Operating Margin (TTM)

ABOS0.0%

ORGO0.0%

EBITDA Margin (TTM)

ABOS0.0%

ORGO-2.0%

Net Margin (TTM)

ABOS0.0%

ORGO-23.1%

FCF Margin (TTM)

ABOSN/A

ORGO4.6%

Net Income (TTM)

ABOS$-105M

ORGO$-106M

FCF (TTM)

ABOS$-92M

ORGO$21M

EPS (TTM)

ABOS-$1.45

ORGO-$0.82

ROE (TTM)

ABOS-13627.0%

ORGO-2260.0%

ROA (TTM)

ABOS-8164.0%

ORGO-1654.0%

ROIC (TTM)

ABOS-9709.0%

ORGO-2187.0%

Cash

ABOS$59M

ORGO$46M

Debt

ABOS$32M

ORGO$12M

Net Cash/Debt

ABOS$28M

ORGO$34M

Current Ratio (TTM)

ABOS2.47x

ORGO3.52x

Quick Ratio (TTM)

ABOS2.38x

ORGO2.66x

Debt/Equity (TTM)

ABOS0.55x

ORGO0.04x

Debt/Assets (TTM)

ABOS0.0%

ORGO0.0%

Interest Coverage (TTM)

ABOSN/A

ORGON/A

Net Debt/EBITDA (TTM)

ABOS0.00x

ORGO0.00x

Beta

ABOS0.30

ORGO1.44

52W Performance

ABOS13.8%

ORGO-68.8%

YTD Performance

ABOS5.9%

ORGO-72.2%

% from 52W High

ABOS-40.6%

ORGO-81.8%

% from 52W Low

ABOS42.7%

ORGO3.2%

Asset Turnover (TTM)

ABOS0.00x

ORGO0.90x

FCF Yield (TTM)

ABOS-59.4%

ORGO12.6%

Earnings Yield (TTM)

ABOS-68.0%

ORGO-63.8%

Dividend Yield (TTM)

ABOSN/A

ORGON/A

Rule of 40

ABOS0.0

ORGO11.1

EV/GP/RG

ABOSN/A

ORGO0.01

Ticker research

View ABOS research View ORGO research

Metric	ABOS Acumen Pharmaceuticals Inc	ORGO Organogenesis Holdings Inc
Market & Valuation
Market Cap	$155M	$166M
Enterprise Value	$127M	$132M
Price	$2.14	$1.29
P/E Ratio	N/A	N/A
P/S Ratio	102.45x	0.36x
EV/Sales	0.00x	0.29x
EV/EBITDA	0.00x	7.37x
P/B Ratio	2.58x	0.59x
P/FCF Ratio	N/A	7.96x
EV/FCF	-1.38x	6.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.74x
Revenue & Growth
Revenue (TTM)	$0	$457M
Revenue Growth (YoY)	N/A	6.5%
Forward Rev Growth	1135.7%	37.6%
Profitability
Gross Margin (TTM)	0.0%	70.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-2.0%
Net Margin (TTM)	0.0%	-23.1%
FCF Margin (TTM)	N/A	4.6%
Net Income (TTM)	$-105M	$-106M
FCF (TTM)	$-92M	$21M
EPS (TTM)	-$1.45	-$0.82
ROE (TTM)	-13627.0%	-2260.0%
ROA (TTM)	-8164.0%	-1654.0%
ROIC (TTM)	-9709.0%	-2187.0%
Financial Health
Cash	$59M	$46M
Debt	$32M	$12M
Net Cash/Debt	$28M	$34M
Current Ratio (TTM)	2.47x	3.52x
Quick Ratio (TTM)	2.38x	2.66x
Debt/Equity (TTM)	0.55x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.30	1.44
52W Performance	13.8%	-68.8%
YTD Performance	5.9%	-72.2%
% from 52W High	-40.6%	-81.8%
% from 52W Low	42.7%	3.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.90x
FCF Yield (TTM)	-59.4%	12.6%
Earnings Yield (TTM)	-68.0%	-63.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	11.1
EV/GP/RG	N/A	0.01
Ticker research	View ABOS research	View ORGO research